2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 1229

Factors Affecting FRAX Score Calculation & Treatment in Practice
Abstract Number: 1230

Comparative Study of Frax® Score in Ecuadorian Population
Abstract Number: 1231

Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence
Abstract Number: 1232

The Perceived Impact of Recent-Onset Psoriatic Arthritis Is Different between Genders: A Spanish Multicenter Experience
Abstract Number: 1233

Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience
Abstract Number: 1234

How Machine Learning Statistics Can Change the Game of Data Analysis in Rheumatology: The Example a Study with 170 Patients with Rheumatoid Arthritis (ra) or Axial Spondyloarthritis (axspa)
Abstract Number: 1235

Perceived Stress and Fatigue in Systemic Lupus Erythematosus
Abstract Number: 1236

The Influence of Testimonials on Patient Decision-Making
Abstract Number: 1237

Group Strength Training in Rheumatology Patients: Results of an Exercise Survey
Abstract Number: 1238

The Development of the Lupus Foundation of America—Rapid Evaluation of Activity in Lupus (LFA-REAL™) Patient-Reported Outcome (PRO) to Evaluate Lupus Disease Activity
Abstract Number: 1239

Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients
Abstract Number: 1240

Active Disease Is Associated with Dependency in Inflammatory Arthritis
Abstract Number: 1241

Understanding Differences in Patient Definitions of RA Flares Using Omeract Core Domains
Abstract Number: 1242

Impact of Social Support and Illness Perception on the Transition of Pediatric SLE Patients to Adult Care
Abstract Number: 1243

Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].